Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
Companies mentioned: Conexeu Sciences Inc. (NASDAQ:CNXU), Integra LifeSciences Holdings Corporation (NASDAQ:IART), Evolus, Inc. (NASDAQ:EOLS), Bioventus Inc. (NASDAQ:BVS), Mesoblast Limited (NASDAQ:MESO) KEY TAKEAWAYS A fresh Nasdaq debut. Conexeu Sciences Inc. (Nasdaq:CNXU) began trading on May 21, 2026, marking the public-market entry of a Reno-based regenerative tissue platform company targeting wound care, breast reconstruction, and aesthetic medicine […]
SpaceX IPO Set to Lift the Whole Space Sector — And One NYSE American Operator Just Stepped Into a Capability NASA Has Asked Industry to Rebuild
USA News Group News Commentary — CAPE CANAVERAL, Fla., May 22, 2026 — Key Takeaways: A Yahoo Finance segment yesterday laid out how the looming SpaceX IPO is set to act as “rocket fuel” for space ETFs and the broader space economy, with the June Nasdaq listing aiming to raise as much as US$75 billion […]